Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (12): 1248-1259.doi: 10.3969/j.issn.1000-6621.2021.12.005
• Original Articles • Previous Articles Next Articles
ZHANG Hui*, CHENG Jun, YU Yan-ling, SHEN Xin, LU Wei, WANG Xiao-meng, YAO Yu-xia, HOU Shuang-yi, LI Jian-wei, ZHAO Jin-ming, XIA Lan, XU Lin, ZHANG Can-you, ZHAO Fei, XIA Yin-yin, CHEN Hui, WANG Li-xia()
Received:
2021-09-10
Online:
2021-12-10
Published:
2021-12-01
Contact:
WANG Li-xia
E-mail:wanglx@chinacdc.cn
ZHANG Hui, CHENG Jun, YU Yan-ling, SHEN Xin, LU Wei, WANG Xiao-meng, YAO Yu-xia, HOU Shuang-yi, LI Jian-wei, ZHAO Jin-ming, XIA Lan, XU Lin, ZHANG Can-you, ZHAO Fei, XIA Yin-yin, CHEN Hui, WANG Li-xia. Evaluation of the effectiveness of community-based pulmonary tuberculosis active case-finding among key populations: a multicenter prospective cohort study[J]. Chinese Journal of Antituberculosis, 2021, 43(12): 1248-1259. doi: 10.3969/j.issn.1000-6621.2021.12.005
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.12.005
特征 | 2013年 (42684名) | 2014年 (41732名) | 2015年 (42441名) |
---|---|---|---|
性别 | |||
男性 | 19930(46.7) | 19582(46.9) | 20020(47.2) |
女性 | 22754(53.3) | 22150(53.1) | 22421(52.8) |
年龄组(岁) | |||
0~14 | 108(0.3) | 115(0.3) | 169(0.4) |
15~24 | 124(0.3) | 103(0.3) | 122(0.3) |
25~34 | 207(0.5) | 213(0.5) | 249(0.6) |
35~44 | 524(1.2) | 463(1.1) | 490(1.2) |
45~54 | 1326(3.1) | 1312(3.1) | 1337(3.1) |
55~64 | 2406(5.6) | 2313(5.5) | 2331(5.5) |
≥65 | 37989(89.0) | 37213(89.2) | 37743(88.9) |
职业 | |||
儿童、学生 | 242(0.6) | 277(0.7) | 3519(0.8) |
教师 | 208(0.5) | 205(0.5) | 244(0.6) |
服务人员 | 251(0.6) | 283(0.7) | 298(0.7) |
医务人员 | 88(0.2) | 95(0.2) | 105(0.3) |
工人 | 1024(2.4) | 1091(2.6) | 1148(2.7) |
农、牧、渔(船)民 | 23368(54.7) | 24572(58.9) | 25716(60.6) |
干部职员 | 337(0.8) | 358(0.9) | 370(0.9) |
离退人员 | 10146(23.8) | 9911(23.7) | 9311(21.9) |
家务及待业 | 3507(8.2) | 3441(8.2) | 3383(8.0) |
其他 | 1009(2.4) | 987(2.4) | 999(2.3) |
不详 | 2504(5.8) | 512(1.2) | 516(1.2) |
文化程度 | |||
文盲或半文盲 | 14306(33.5) | 14267(34.2) | 13922(32.8) |
小学 | 15006(35.2) | 15340(36.8) | 15765(37.2) |
初中 | 6607(15.5) | 6838(16.4) | 7132(16.8) |
高中或中专 | 3421(8.0) | 3359(8.0) | 3565(8.4) |
大专及以上 | 1501(3.5) | 1535(3.7) | 1620(3.8) |
不详 | 1843(4.3) | 393(0.9) | 437(1.0) |
城乡 | |||
城镇 | 15148(35.5) | 15191(36.4) | 14648(34.5) |
乡村 | 27536(64.5) | 26541(63.6) | 27793(65.5) |
地区 | |||
东部 | 16185(37.9) | 15526(37.2) | 16451(38.7) |
中部 | 9479(22.2) | 9347(22.4) | 9366(22.1) |
西部 | 17020(39.9) | 16859(40.4) | 16624(39.2) |
吸烟史 | |||
从不吸烟 | 34051(79.8) | 32803(78.6) | 32445(76.4) |
过去吸烟 | 2024(4.7) | 1920(4.6) | 1889(4.5) |
现在吸烟 | 6490(15.2) | 6449(15.5) | 6823(16.1) |
缺失 | 119(0.3) | 560(1.3) | 1284(3.0) |
饮酒史 | |||
从不饮酒 | 34282(80.3) | 32854(78.7) | 32540(76.7) |
曾经饮酒 | 1556(3.7) | 1472(3.5) | 1467(3.5) |
现在饮酒 | 6671(15.6) | 6786(16.3) | 7095(16.7) |
缺失 | 175(0.4) | 620(1.5) | 1339(3.1) |
体质量指数 | |||
<18.5 | 4561(10.7) | 4620(11.1) | 5153(12.1) |
18.5~23.9 | 25722(60.3) | 24962(59.8) | 24832(58.5) |
≥24.0 | 12401(29.0) | 12150(29.1) | 12456(29.4) |
重点人群 | 人数 (名) | 核心信息总 知晓数(条) | 总知晓 率(%) |
---|---|---|---|
2013年 | |||
全部重点人群 | 42684 | 73066 | 34.2 |
65岁及以上老年人 | 37989 | 61723 | 32.5 |
已知糖尿病患者 | 5642 | 12340 | 43.7 |
既往结核病患者 | 1684 | 4633 | 55.0 |
肺结核患者密切接触者 | 593 | 992 | 33.5 |
HIV/AIDS者 | 83 | 199 | 48.0 |
2014年 | |||
全部重点人群 | 41732 | 119416 | 57.2 |
65岁及以上老年人 | 37219 | 104072 | 55.9 |
已知糖尿病患者 | 5855 | 19387 | 66.2 |
既往结核病患者 | 1620 | 5575 | 68.8 |
肺结核患者密切接触者 | 756 | 2278 | 60.3 |
HIV/AIDS者 | 82 | 307 | 74.9 |
2015年 | |||
全部重点人群 | 42441 | 142629 | 67.2 |
65岁及以上老年人 | 37771 | 124315 | 65.8 |
已知糖尿病患者 | 6002 | 22580 | 75.2 |
既往结核病患者 | 1488 | 5885 | 79.1 |
肺结核患者密切接触者 | 1126 | 3972 | 70.6 |
HIV/AIDS者 | 76 | 323 | 85.0 |
重点人群 | 筛查数 (名) | 任一症状 [例(发生率,%)] | 规划可疑症状 [例(发生率,%)] | 研究可疑症状 [例(发生率,%)] | ||||
---|---|---|---|---|---|---|---|---|
2013年 | ||||||||
全部重点人群 | 42684 | 1831(4.3) | 932(2.2) | 1025(2.4) | ||||
65岁及以上老年人 | 37989 | 1509(4.0) | 731(1.9) | 798(2.1) | ||||
已知糖尿病患者 | 5642 | 268(4.8) | 152(2.7) | 167(3.0) | ||||
既往结核病患者 | 1684 | 281(16.7) | 178(10.6) | 207(12.3) | ||||
肺结核患者密切接触者 | 593 | 23(3.9) | 14(2.4) | 14(2.4) | ||||
HIV/AIDS者 | 83 | 3(3.6) | 0(0.0) | 0(0.0) | ||||
2014年 | ||||||||
全部重点人群 | 41732 | 491(1.2) | 38(0.1) | 40(0.1) | ||||
65岁及以上老年人 | 37219 | 423(1.1) | 30(0.1) | 32(0.1) | ||||
已知糖尿病患者 | 5855 | 99(1.7) | 14(0.2) | 14(0.2) | ||||
既往结核病患者 | 1620 | 53(3.3) | 7(0.4) | 7(0.4) | ||||
肺结核患者密切接触者 | 756 | 3(0.4) | 0(0.0) | 0(0.0) | ||||
HIV/AIDS者 | 82 | 0(0.0) | 0(0.0) | 0(0.0) | ||||
重点人群 | 筛查数 (名) | 任一症状 [例(发生率,%)] | 规划可疑症状 [例(发生率,%)] | 研究可疑症状 [例(发生率,%)] | ||||
2015年 | ||||||||
全部重点人群 | 42441 | 349(0.8) | 237(0.6) | 258(0.6) | ||||
65岁及以上老年人 | 37771 | 307(0.8) | 204(0.5) | 221(0.6) | ||||
已知糖尿病患者 | 6002 | 62(1.0) | 36(0.6) | 43(0.7) | ||||
既往结核病患者 | 1488 | 34(2.3) | 27(1.8) | 28(1.9) | ||||
肺结核患者密切接触者 | 1126 | 7(0.6) | 7(0.6) | 7(0.6) | ||||
HIV/AIDS者 | 76 | 0(0.0) | 0(0.0) | 0(0.0) |
重点人群 | 筛查数 (名) | 结核病或疑似 结核病病灶 [例(构成比, %)] | 其他病灶 [例(构成 比,%)] |
---|---|---|---|
2013年 | |||
全部重点人群 | 37538 | 1289(3.3) | 1736(4.6) |
65岁及以上老年人 | 33717 | 913(2.7) | 1652(4.9) |
已知糖尿病患者 | 5018 | 87(1.7) | 103(2.1) |
既往结核病患者 | 1505 | 462(30.7) | 116(7.7) |
肺结核患者密切接触者 | 344 | 18(5.2) | 6(1.7) |
HIV/AIDS者 | 59 | 5(8.5) | 1(1.7) |
2014年 | |||
全部重点人群 | 37070 | 1109(3.0) | 1205(3.3) |
65岁及以上老年人 | 33686 | 872(2.6) | 1153(3.4) |
已知糖尿病患者 | 5037 | 100(2.0) | 128(2.5) |
既往结核病患者 | 1305 | 400(30.7) | 63(4.8) |
肺结核患者密切接触者 | 489 | 9(1.8) | 8(1.6) |
HIV/AIDS者 | 62 | 4(6.5) | 0(0.0) |
2015年 | |||
全部重点人群 | 36483 | 1047(2.9) | 690(1.9) |
65岁及以上老年人 | 33268 | 842(2.5) | 655(2.0) |
已知糖尿病患者 | 5121 | 78(1.5) | 63(1.2) |
既往结核病患者 | 1185 | 338(28.5) | 60(5.1) |
肺结核患者密切接触者 | 626 | 16(2.6) | 4(0.6) |
HIV/AIDS者 | 68 | 2(2.9) | 0(0.0) |
重点人群 | 菌阳肺结核 | 活动性肺结核 | |||||
---|---|---|---|---|---|---|---|
全部患者(例) | 主动发现(例) | 贡献率(%) | 全部患者(例) | 主动发现(例) | 贡献率(%) | ||
2013年 | |||||||
全部重点人群 | 84 | 77 | 91.7 | 255 | 244 | 95.7 | |
65岁及以上老年人 | 56 | 52 | 92.9 | 174 | 167 | 96.0 | |
已知糖尿病患者 | 11 | 11 | 100.0 | 24 | 23 | 95.8 | |
既往结核病患者 | 31 | 28 | 90.3 | 90 | 84 | 93.3 | |
肺结核患者密切接触者 | 2 | 2 | 2/2 | 9 | 9 | 9/9 | |
HIV/AIDS者 | 1 | 0 | 0.0 | 3 | 2 | 2/3 | |
2014年 | |||||||
全部重点人群 | 58 | 44 | 75.9 | 247 | 200 | 81.0 | |
65岁及以上老年人 | 42 | 35 | 83.3 | 186 | 162 | 87.1 | |
已知糖尿病患者 | 2 | 1 | 1/2 | 18 | 17 | 94.4 | |
既往结核病患者 | 23 | 18 | 78.3 | 90 | 69 | 76.7 | |
肺结核患者密切接触者 | 1 | 0 | 0.0 | 2 | 0 | 0.0 | |
HIV/AIDS者 | 0 | 0 | 0.0 | 1 | 1 | 1/1 | |
2015年 | |||||||
全部重点人群 | 53 | 36 | 67.9 | 153 | 112 | 73.2 | |
65岁及以上老年人 | 39 | 29 | 74.4 | 122 | 96 | 78.7 | |
已知糖尿病患者 | 5 | 1 | 1/5 | 11 | 6 | 54.6 | |
既往结核病患者 | 7 | 5 | 5/7 | 20 | 12 | 60.0 | |
肺结核患者密切接触者 | 1 | 1 | 1/1 | 6 | 5 | 5/6 | |
HIV/AIDS者 | 1 | 0 | 0.0 | 1 | 0 | 0.0 | |
合计 | |||||||
全部重点人群 | 195 | 157 | 80.5 | 655 | 556 | 84.9 | |
65岁及以上老年人 | 137 | 116 | 84.7 | 482 | 425 | 88.2 | |
已知糖尿病患者 | 18 | 13 | 72.2 | 53 | 46 | 86.8 | |
既往结核病患者 | 61 | 51 | 83.6 | 200 | 165 | 82.5 | |
肺结核患者密切接触者 | 4 | 3 | 3/4 | 17 | 14 | 82.4 | |
HIV/AIDS者 | 2 | 0 | 0.0 | 5 | 3 | 3/5 |
影响因素 | 患者数 (例) | 主动发现 | χ2值 | P值 | OR(95%CI)值 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
患者数(例) | 贡献率(%) | ||||||||||
性别 | 0.025 | 0.875 | |||||||||
男性 | 474 | 403 | 85.0 | 1.04(0.65~1.67) | |||||||
女性 | 181 | 153 | 84.5 | - | |||||||
年龄组(岁) | 28.574 | <0.01 | |||||||||
15~24 | 12 | 7 | 58.3 | - | |||||||
25~34 | 15 | 8 | 53.3 | 0.82(0.18~3.78) | |||||||
35~44 | 22 | 17 | 77.3 | 2.43(0.53~11.11) | |||||||
45~54 | 53 | 39 | 73.6 | 1.99(0.54~7.30) | |||||||
55~64 | 71 | 60 | 84.5 | 3.90(1.05~14.52) | |||||||
≥65 | 482 | 425 | 88.2 | 5.33(1.64~17.34) | |||||||
文化程度 | 25.008 | <0.01 | |||||||||
文盲或半文盲 | 216 | 191 | 88.4 | 6.37(1.81~22.40) | |||||||
小学 | 267 | 236 | 88.4 | 6.34(1.83~22.02) | |||||||
初中 | 125 | 92 | 73.6 | 2.32(0.66~8.12) | |||||||
高中或中专 | 36 | 31 | 86.1 | 5.17(1.13~23.55) | |||||||
大专及以上 | 11 | 6 | 54.5 | - | |||||||
城乡 | 3.674 | 0.055 | |||||||||
城镇 | 132 | 105 | 79.5 | - | |||||||
乡村 | 523 | 451 | 86.2 | 1.61(0.99~2.63) | |||||||
地区 | 6.974 | 0.031 | |||||||||
东部 | 146 | 118 | 80.8 | - | |||||||
中部 | 171 | 139 | 81.3 | 1.03(0.59~1.81) | |||||||
西部 | 338 | 299 | 88.5 | 1.82(1.07~3.09) | |||||||
吸烟史 | 1.370 | 0.242 | |||||||||
有 | 198 | 173 | 87.4 | - | |||||||
无 | 457 | 383 | 83.8 | 0.75(0.46~1.22) | |||||||
饮酒史 | 0.324 | 0.569 | |||||||||
有 | 183 | 153 | 83.6 | - | |||||||
无 | 472 | 403 | 85.4 | 1.15(0.72~1.83) | |||||||
体质量指数 | 0.465 | 0.793 | |||||||||
<18.5 | 107 | 93 | 86.9 | 1.29(0.59~2.85) | |||||||
18.5~23.9 | 456 | 386 | 84.6 | 1.07(0.58~1.97) | |||||||
≥24 | 92 | 77 | 83.7 | - | |||||||
症状和就诊知识 | 2.062 | 0.357 | |||||||||
全知晓 | 269 | 234 | 87.0 | - | |||||||
知晓其一 | 119 | 97 | 81.5 | 0.66(0.37~1.18) | |||||||
全不知晓 | 267 | 225 | 84.3 | 0.80(0.49~1.30) | |||||||
影响因素 | 患者数 (例) | 主动发现 | χ2值 | P值 | OR(95%CI)值 | ||||||
患者数(例) | 贡献率(%) | ||||||||||
肺结核规划症状 | 5.219 | 0.022 | |||||||||
有 | 69 | 65 | 94.2 | - | |||||||
无 | 586 | 491 | 83.8 | 0.32(0.11~0.89) | |||||||
糖尿病 | 0.163 | 0.686 | |||||||||
有 | 53 | 46 | 86.8 | - | |||||||
无 | 602 | 510 | 84.7 | 0.84(0.37~1.93) | |||||||
既往结核病 | 1.277 | 0.259 | |||||||||
是 | 200 | 165 | 82.5 | - | |||||||
否 | 455 | 391 | 85.9 | 1.30(0.83~2.03) | |||||||
肺结核患者密切接触者 | - | 0.732a | |||||||||
是 | 17 | 14 | 82.4 | - | |||||||
否 | 638 | 542 | 85.0 | 1.21(0.34~4.29) | |||||||
HIV/AIDS者 | - | 0.166a | |||||||||
是 | 5 | 3 | 3/5 | - | |||||||
否 | 650 | 553 | 85.1 | 3.80(0.63~23.04) |
变量 | 赋值 | 变量 | 赋值 |
---|---|---|---|
是否主动发现 | 主动发现=1;非主动发现=0 | 饮酒史 | 有=1;无=0; |
性别 | 男性=1;女性=2 | ||
体质量指数 | <18.5=1;18.5~23.9=2;≥24=3 | ||
年龄组 | 15~24岁=1;25~34岁=2;35~44岁=3;45~54岁=4;55~64岁=5;≥65岁=6 | ||
症状和就诊知识 | 全知晓=1;知晓其一=2;全不知晓=3 | ||
肺结核规划症状 | 有=1;无=0 | ||
文化程度 | 文盲或半文盲=1;小学=2;初中=3;高中或中专=4;大专及以上=5 | ||
糖尿病 | 有=1;无=0 | ||
既往结核病 | 是=1;否=0; | ||
城乡 | 城镇=1;乡村=2 | ||
肺结核患者密切接触者 | 是=1;否=0 | ||
地区 | 东部=1;中部=2;西部=3 | ||
HIV/AIDS者 | 是=1;否=0 | ||
吸烟史 | 有=1;无=0; |
影响因素 | β值 | s | Wald χ2值 | P值 | 调整OR(95%CI)值 | |||||
---|---|---|---|---|---|---|---|---|---|---|
性别(以“女性”为参照) | ||||||||||
男性 | 1.056 | 0.860 | 0.526 | 0.468 | 1.20(0.73~1.99) | |||||
年龄组(以“15~24岁”为参照) | ||||||||||
25~34岁 | -0.225 | 0.895 | 0.063 | 0.802 | 0.80(0.14~4.62) | |||||
35~44岁 | 1.472 | 0.873 | 2.840 | 0.092 | 4.36(0.79~24.14) | |||||
45~54岁 | 1.104 | 0.710 | 2.104 | 0.147 | 3.02(0.68~13.40) | |||||
55~64岁 | 1.972 | 0.769 | 6.580 | 0.010 | 7.18(1.59~32.39) | |||||
≥65岁 | 2.604 | 0.718 | 13.167 | 0.000 | 13.52(3.31~55.16) | |||||
影响因素 | β值 | s | Wald χ2值 | P值 | 调整OR(95%CI)值 | |||||
地区(以“东部”为参照) | ||||||||||
中部 | 0.345 | 0.309 | 1.245 | 0.265 | 1.41(0.77~2.59) | |||||
西部 | 0.891 | 0.289 | 9.530 | 0.002 | 2.44(1.38~4.29) | |||||
症状和就诊知识(以“全知晓”为参照) | ||||||||||
知晓其一 | -0.829 | 0.326 | 6.462 | 0.011 | 0.44(0.23~0.83) | |||||
全不知晓 | -0.540 | 0.274 | 3.885 | 0.049 | 0.58(0.34~1.00) | |||||
肺结核规划症状(以“有”为参照) | ||||||||||
无肺结核规划症状 | -1.884 | 0.589 | 10.223 | 0.001 | 0.15(0.05~0.48) |
[1] | World Health Organization. Global tuberculosis report 2014. Geneva: World Health Organization, 2014. |
[2] | World Health Organization. Systematic screening for active tuberculosis: principles and recommendations. Geneva: World Health Organization, 2013. |
[3] | World Health Organization. WHO consolidated guidelines on tuberculosis. Module 2: screening-systematic screening for tuberculosis disease. Geneva: World Health Organization, 2021. |
[4] |
Ho J, Fox GJ, Marais BJ. Passive case-finding for tuberculosis is not enough. Int J Mycobacteriol, 2016, 5(4):374-378. doi: 10.1016/j.ijmyco.2016.09.023.
doi: 10.1016/j.ijmyco.2016.09.023 URL |
[5] | World Health Organization. The End TB Strategy. Geneva: World Health Organization, 2015. |
[6] | 卫生部疾病预防控制局, 卫生部医政司, 中国疾病预防控制中心. 中国结核病防治规划实施工作指南 (2008年版). 北京: 中国协和医科大学出版社, 2009. |
[7] | 全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告. 中国防痨杂志, 2012, 34(8):485-508. |
[8] |
Marks GB, Nguyen NV, Nguyen PTB, et al. Community-wide screening for tuberculosis in a high-prevalence setting. N Engl J Med, 2019, 381(14):1347-1357. doi: 10.1056/NEJMoa1902129.
doi: 10.1056/NEJMoa1902129 URL |
[9] |
Kim H, Kim HJ, Oh KH, et al. A Pilot Project of Systematic Tuberculosis Screening in the Elderly in a South Korean Pro-vince. Tuberc Respir Dis (Seoul), 2019, 82(3):194-200. doi: 10.4046/trd.2018.0063.
doi: 10.4046/trd.2018.0063 URL |
[10] |
Camelique O, Scholtissen S, Dousset JP, et al. Mobile community-based active case-finding for tuberculosis among older populations in rural Cambodia. Int J Tuberc Lung Dis, 2019, 23(10):1107-1114. doi: 10.5588/ijtld.18.0611.
doi: 10.5588/ijtld.18.0611 pmid: 31627776 |
[11] | World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020. |
[12] |
Cheng J, Wang L, Zhang H, et al. Diagnostic value of symptom screening for pulmonary tuberculosis in China. PLoS One, 2015, 10(5):e0127725. doi: 10.1371/journal.pone.0127725.
doi: 10.1371/journal.pone.0127725 URL |
[13] |
Chen JO, Qiu YB, Rueda ZV, et al. Role of community-based active case-finding in screening tuberculosis in Yunnan pro-vince of China. Infect Dis Poverty, 2019, 8(1):92. doi: 10.1186/s40249-019-0602-0.
doi: 10.1186/s40249-019-0602-0 URL |
[14] | World Health Organization. Global tuberculosis report 2021. Geneva: World Health Organization, 2021. |
[15] | World Health Organization. A systematic review of the sensitivity and specificity of symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative persons and persons with unknown HIV status. Geneva: World Health Organization, 2013. |
[16] | World Health Organization. Chest radiography in tuberculosis detection: summary of current who recommendations and guidance on programmatic approaches. Geneva: World Health Organization, 2016 |
[17] |
Shewade HD, Gupta V, Ghule VH, et al. Impact of advocacy, communication, social mobilization and active case-finding on TB notification in Jharkhand, India. J Epidemiol Glob Health, 2019, 9(4):233-242. doi: 10.2991/jegh.k.190812.002.
doi: 10.2991/jegh.k.190812.002 pmid: 31854164 |
[18] |
Aye S, Majumdar SS, Oo MM, et al. Evaluation of a tuberculosis active case-finding project in peri-urban areas, Myanmar: 2014-2016. Int J Infect Dis, 2018, 70:93-100. doi: 10.1016/j.ijid.2018.02.012.
doi: 10.1016/j.ijid.2018.02.012 URL |
[1] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[2] | Sun Danyuchen, Liu Yuhong. Research progress on active case finding of tuberculosis in the elderly population: a literature review [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 96-101. |
[3] | Bao Xundi, Liang Suo, Li Jun, Ye Qian, Wu Dandan, Wang Shu, LI Yue, Ding Yunsheng, Liu Jie. Analysis of Mycobacterium tuberculosis drug resistance monitoring in Anhui Province from 2016 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(5): 531-537. |
[4] | Guo Jing, Pang Jialei, Gao Weiwei, Cai Min, Lin Feishen, Zhang Xia. Phenotypic drug resistance spectrum analysis of adult patients with active pulmonary tuberculosis complicated with diabetes mellitus in Nanjing from 2019 to 2021 [J]. Chinese Journal of Antituberculosis, 2024, 46(1): 62-69. |
[5] | Zhuo Wenji, Zhang Chenchen, Chen Xunxun, Wei Wenjing, Yu Meiling, Peng Kehao, Xu Liuyue, Chen Yanmei. Analysis of drug resistance characteristics of pulmonary tuberculosis in children in Guangdong, 2014—2020 [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 687-692. |
[6] | Teng Rencong, Li Tao, LI Yuhong, Yang Chenlu, Zhang Canyou, Zhao Yanlin, Zhang Hui. Analysis of registration records of elderly pulmonary tuberculosis patients aged 65 and above in China,2015—2021 [J]. Chinese Journal of Antituberculosis, 2023, 45(4): 367-371. |
[7] | Zhou Yan, Zhou Meng, Peng Jun, Duan Qionghong, Chen Jun, Zhou Meilan, Zhang Yunxia, Liang Jun. Analysis on transmission of multidrug-resistant pulmonary tuberculosis in family [J]. Chinese Journal of Antituberculosis, 2023, 45(2): 195-199. |
[8] | Tao Liying, Xu Zheng, Zhao Xin, Li Yanyuan, Li Yamin, Xu Yan, Zhang Yanan, Gao Zhidong. Analysis of tuberculosis screening results among freshmen of high schools and below in Beijing,2021 [J]. Chinese Journal of Antituberculosis, 2023, 45(1): 111-115. |
[9] | CHEN Yan-mei, WEN Wen-pei, WU Hui-zhong, XU Liu-yue, PENG Ke-hao, YU Mei-ling. Analysis of monitoring results of tuberculosis drug-resistance in Guangdong Province from 2016 to 2020 [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 685-689. |
[10] | WANG Ning, ZHENG Lu-yao, MENG Xiu-juan, LIU Hai-ting, DING Yang-ming, YAO Rong, GUO Shao-chen, LU Yu. Distribution characteristics of N-acetyltransferase-2 genotypes and comparison methods of different genotyping in Chinese population [J]. Chinese Journal of Antituberculosis, 2022, 44(6): 625-634. |
[11] | Li Meng, Chen Chuang, Gao Qian. Strengthen the screening of close contacts to improve the detection of tuberculosis patient [J]. Chinese Journal of Antituberculosis, 2022, 44(12): 1253-1255. |
[12] | YANG Ting-ting, GAO Qian. The tuberculosis drug-resistance and transmission surveillance network based on whole genome sequencing data [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 645-648. |
[13] | BAI Hua, GUO Jing-wei, HU Pei-lei, YI Song-lin, WEN Jia, LIU Feng-ping, TAN Yun-hong, BAI Li-qiong. Analysis of drug resistance surveillance results of Mycobacterium tuberculosis in Hu’nan Province from 2014 to 2018 [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 364-369. |
[14] | CHENG Jun, ZHANG Can-you, CHEN Hui, ZHANG Hui, ZHAO Yan-lin. Strengthen tuberculosis control strategy in key populations according to local conditions [J]. Chinese Journal of Antituberculosis, 2021, 43(3): 217-221. |
[15] | SU Wei, LI Ren-zhong, RUAN Yun-zhou, JIANG Jia-wen, WANG Meng, XIE Tian, WANG Zhong-sheng, XU Wan-guang, FANG Guan-chen, ZENG Yan, TANG Wen-fang. Effect of sputum sample quality intervention on the positive detection rate of etiology in newly diagnosed pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2021, 43(12): 1269-1274. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||